Episode 46: SPONSORED Endotoxemia: The Underlying Reason Most of Your Patients Need Immunoglobulins

Endotoxemia. A fundamental driver of chronic disease. What is it?
And more importantly, what do we do to address it? In my podcast
with Dr. Jill Carnahan this month, she unleashes a torrent of
compelling science and clinical savvy on all things endotoxemia.
From heart disease and diabetes to autoimmunity (genetic or
acquired) and mast cell activation, Dr. Carnahan is clear that
pathological intestinal permeability (she discusses testing, but at
this point in her career believes most everyone who sees her with
chronic disease has IP) drives inflammation by allowing excess
microbial endotoxins- primarily as lipopolysaccharide (LPS)- to
enter circulation. Focused on root cause functional medicine
(toxins, diet, infection, genetics), she concurrently heals the gut
to drop the inflammatory burden. A key intervention for Jill is
sugar-free, GMO-free, serum-derived bovine immunoglobulin (SBI),
and we spend quite a bit of time on why SBI is crucial. With 43
human trials behind it, if you are not using SBI yet, you’ll be
compelled to start, I suspect. We also have a fun dialogue on the
role of fatty acids and toll-like receptor activation, connected
directly to LPS. Jill shares a handful of very compelling case
vignettes AND talks candidly about how she set up an extremely
successful functional medicine practice and positioned herself as
an expert in the field. And let me know: will you be changing how
you prescribe high fat diets based on the research we discuss?